A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell Lines-Reference-Cited by-同舟云学术

A SAR Study of Novel Antiproliferative Ruthenium and Osmium Complexes with Quinoxalinone Ligands in Human Cancer Cell Lines

Published:2012-03-27 Issue:7 Volume:55 Page:3398-3413
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ginzinger Werner¹,Mühlgassner Gerhard¹,Arion Vladimir B.¹,Jakupec Michael A.¹,Roller Alexander¹,Galanski Markus¹,Reithofer Michael¹,Berger Walter²,Keppler Bernhard K.¹

Affiliation:

1. University of Vienna, Institute of Inorganic Chemistry, Währinger Strasse 42, A-1090 Vienna, Austria

2. Medical University of Vienna, Department of Medicine I, Institute of Cancer Research, Borschkeg. 8a, A-1090 Vienna, Austria

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm3000906

Reference65 articles.

1. Antitumour metal compounds: more than theme and variations

2. Medicinal Applications of Metal Complexes Binding to Biological Macromolecules

3. Metal based drugs: from serendipity to design

4. Ruthenium metallopharmaceuticals

5. Ruthenium Anticancer Compounds: Challenges and Expectations

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Mitochondria‐Localized Luminescent Ruthenium(II) Metallodrugs as Anticancer Agents;ChemMedChem;2023-10-30

2. Visible‐Light‐Driven Multicomponent Radical Cascade Versatile Alkylation of Quinoxalinones Enabled by Electron Donor Acceptor Complex in Water;Advanced Synthesis & Catalysis;2023-03-24

3. Ruthenium(II)‐Dithiocarbazates as Anticancer Agents: Synthesis, Solution Behavior, and Mitochondria‐Targeted Apoptotic Cell Death;Chemistry – A European Journal;2023-02-24

4. In silico investigation of organometallic complexes for identification of RNase A inhibitor;Journal of Organometallic Chemistry;2023-01

5. Second and third-row transition metal compounds containing benzimidazole ligands: An overview of their anticancer and antitumour activity;Coordination Chemistry Reviews;2022-12